Summit Therapeutics (SMMT) Tax Provisions (2017 - 2020)

Summit Therapeutics (SMMT) has 4 years of Tax Provisions data on file, last reported at -$21000.0 in Q4 2020.

• Quarterly Tax Provisions rose 99.09% year-over-year to -$21000.0 in Q4 2020, while the trailing twelve-month figure through Sep 2021 was -$21000.0 (up 99.16% YoY) and the FY2020 annual result came in at -$213000.0, down 691.67% from the prior year.
• Tax Provisions climbed to -$21000.0 in Q4 2020, from -$56000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $654347.7 in Q3 2018 to a low of -$2.3 million in Q4 2019.
• A 4-year average of -$805820.3 and a median of -$990828.5 in 2019 frame the typical range for Tax Provisions.
• Annual changes were most pronounced in 2018 — Tax Provisions soared 139.53% — and 2019, when it slumped 305.77%.
• Tracing SMMT's Tax Provisions over 4 years: stood at -$1.9 million in 2017, then grew by 14.54% to -$1.7 million in 2018, then plunged by 39.31% to -$2.3 million in 2019, then soared by 99.09% to -$21000.0 in 2020.
• The last three Tax Provisions figures came in at -$21000.0 (Q4 2020), -$56000.0 (Q3 2020), and -$191000.0 (Q2 2020), per Business Quant data.